Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dequalinium versus usual care antibiotics for bacterial vaginosis
ISRCTN91800263Phase 4Completed
- Sponsor
- Leeds Teaching Hospitals NHS Trust
- Start
- Aug 2021
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
01
Overview
Phase 4, randomised, open-label trial of dequalinium, metronidazole, clindamycin and tinidazole in bacterial vaginosis (BV) (2 arms), sponsored by Leeds Teaching Hospitals NHS Trust. Started Aug 2021; status: completed.
02
Drugs
dequaliniummetronidazoleclindamycintinidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on ISRCTN91800263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN91800263.